Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo.
PubMed
Paper Journal Title
Nat Chem Biol
Paper Citation Count
64
Paper Publication Year
2021
Bio Mention
Cys113, MYCN, MYCN-driven neuroblastoma, Myc, Pin1, Sulfopin, active, c-Myc target genes, cancer, cancer cell line, cells, murine, oncogenes, pancreatic cancer, peptidyl-prolyl isomerase, prolyl, tumor, tumor suppressors, tumors, zebrafish
Mesh Descriptor
Go
Actions
Author Name
Affiliation
Sirano Dhe-Paganon
Dana-Farber Cancer Institute
Alex Look
Dana-Farber Cancer Institute, Harvard Medical School
Alex Look
Division of Pediatric Hematology/Oncology Boston Children's Hospital
Rosalie C Sears
Oregon Health & Science University
Rosalie C Sears
Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University
Rosalie C Sears
Knight Cancer Institute, Oregon Health & Science University
Rosalie C Sears
Oregon Health & Science University
Rosalie C Sears
Knight Cancer Institute, Oregon Health & Science University
Rosalie C Sears
Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University
Nathanael S Gray
Dana-Farber Cancer Institute
Nathanael S Gray
Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University
Nathanael S Gray
Harvard Medical School
Nathanael S Gray
Dana-Farber Cancer Institute
Nathanael S Gray
Harvard Medical School
Nathanael S Gray
Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University
Nir London
The Weizmann Institute of Science
Nir London
The Weizmann Institute of Science
1 - 17
Column Actions
Search
Datasets